ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ · Healthcare
$6.44-8.00%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $748.75M
- P/E ratio
- —
- EPS
- —
- Volume
- 2,932,953
- 52-week high
- —
- 52-week low
- —
- Open
- $7.00
- Day high
- $7.14
- Day low
- $6.42
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $84.28M | -$171.3M | -$1.74 |
| 2024 | $89.15M | $8M | $0.08 |
| 2023 | $30K | -$54.37M | -$0.57 |
| 2022 | $1.32M | -$34.68M | -$0.87 |
| 2021 | $5.51M | -$20.24M | -$0.70 |
About ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.
- CEO
- Donn Casale
- Employees
- 163
- Country
- US
- IPO date
- Dec 4, 2020
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is ARS Pharmaceuticals, Inc.'s stock price today?
- SPRY is trading at $6.44 as of Jul 20, 2026.
- What is ARS Pharmaceuticals, Inc.'s market cap?
- ARS Pharmaceuticals, Inc. (SPRY) has a market capitalization of $748.75M.
- Does ARS Pharmaceuticals, Inc. pay a dividend?
- ARS Pharmaceuticals, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is ARS Pharmaceuticals, Inc. in?
- ARS Pharmaceuticals, Inc. operates in the Healthcare sector.